Navigation Links
Cantox Announces the Launch of Ashuren Health Sciences Pharmaceutical Division
Date:1/10/2008

MISSISSAUGA, Ontario, BRIDGEWATER, New Jersey and BIRMINGHAM, Alabama, Jan. 10 /PRNewswire/ -- CANTOX HEALTH SCIENCES INC. and CANTOX US INC., a leading international scientific and regulatory consulting firm with specialized expertise in the areas of Pharmaceutical & Healthcare, Food & Nutrition, Chemicals and Agriculture, Biotech & Consumer Products announces the launch of Ashuren Health Sciences as the new name for their Pharmaceutical & Healthcare Division.

For the past 20 years, Cantox has been helping clients resolve complex scientific and toxicology issues, develop scientific and strategic regulatory plans, and facilitating timely regulatory global approvals. Cantox has been optimizing success and minimizing client risk through broad expertise and knowledge.

"The decision to rename the Pharmaceutical & Healthcare Division 'ASHUREN Health Sciences' was taken in order to more accurately represent our expanding global client base and to reflect our diverse international regulatory agency interactions," said Lindsay N. Donald, Vice President of Ashuren Pharmaceutical & Healthcare. "We have been assisting clients with their toxicology and drug development issues in Europe, North America, Asia and Australia."

"In order to rapidly and cost effectively move drugs through development it is imperative to anticipate scientific and regulatory issues ahead of time," commented Anna Metcalfe, Vice President of Regulatory Affairs for Ashuren. "This is where the experience of Ashuren's scientific and regulatory affairs consultants can really aid our pharmaceutical and biotech clients."

About Ashuren

Ashuren Health Sciences is a focused team of scientific and regulatory consultants that can help develop strategies, provide expert advice on all aspects of product development programs, and provide advice on a wide variety of toxicology and regulatory issues for pharmaceutical and related products. With diverse and in-depth experience in pharmaceutical development, our resourceful and innovative team consisting of board-certified toxicologists, regulatory affairs specialists and scientific writers address client's needs and accelerate their development programs. For more information, please visit: http://www.ashuren.com.


'/>"/>
SOURCE Ashuren Health Sciences
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... Cancer experts from Austria, Hungary, Switzerland, and ... new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published ... , Biomarkers are components in the blood, tissue or body fluids that ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)...  Regular discussions on a range of subjects including policies, ... entities said Poloz. Speaking at a lecture to ... he pointed to the country,s inflation target, which is set ... "In certain areas there needs ... economic goals, why not sit down and address strategy together?" ...
Breaking Biology Technology:
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
Breaking Biology News(10 mins):